Here is a curve ball. Peter was absent at the AGM because he wanted to be present when David Suhy announced the SVR for TT-034, cohort 3 at the Liver meeting. Now that would be worth an apology from me but I doubt that I will have to make that apology. The best we can hope for is a comparison of the trial data and the replicon results. If that was announced, then I would be happy.
- Forums
- ASX - By Stock
- BLT
- Interesting article on GT and pharma
Interesting article on GT and pharma, page-9
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)